Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4863494
Max Phase: Preclinical
Molecular Formula: C42H39ClF3N5O7
Molecular Weight: 818.25
Molecule Type: Unknown
Associated Items:
ID: ALA4863494
Max Phase: Preclinical
Molecular Formula: C42H39ClF3N5O7
Molecular Weight: 818.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1C(C(=O)NC(C)(C)C)N(Cc1cc(F)c(F)c(F)c1)C(=O)CCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C42H39ClF3N5O7/c1-5-58-41(57)36-34(26-14-13-24(43)19-30(26)47-36)37(39(55)49-42(2,3)4)51(20-22-17-28(44)35(46)29(45)18-22)33(53)12-7-6-9-23-10-8-11-25-27(23)21-50(40(25)56)31-15-16-32(52)48-38(31)54/h8,10-11,13-14,17-19,31,37,47H,5,7,12,15-16,20-21H2,1-4H3,(H,49,55)(H,48,52,54)
Standard InChI Key: XIOIUMROBDJBEN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 818.25 | Molecular Weight (Monoisotopic): 817.2490 | AlogP: 5.99 | #Rotatable Bonds: 10 |
Polar Surface Area: 157.98 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.31 | CX Basic pKa: | CX LogP: 5.34 | CX LogD: 5.34 |
Aromatic Rings: 4 | Heavy Atoms: 58 | QED Weighted: 0.08 | Np Likeness Score: -0.90 |
1. Wang B, Liu J, Tandon I, Wu S, Teng P, Liao J, Tang W.. (2021) Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries., 219 [PMID:33862513] [10.1016/j.ejmech.2021.113425] |
Source(1):